A cyclin-dependent kinase inhibitor (p21WAF1/CIP1) affects thymidine incorporation in human liver cancer cells
2002
Effect of p21WAF1/CIP1 on Liver Cancer Cells
Sample size: 2
publication
Evidence: moderate
Author Information
Author(s): Gong Y, Deng S, Zhang M, Wang G, Minuk G Y, Burczynski F
Primary Institution: University of Manitoba
Hypothesis
What is the role of p21WAF1/CIP1 in the proliferation of human liver cancer cells?
Conclusion
p21WAF1/CIP1 inhibits DNA synthesis in human liver cancer cells and could be a target for treatment.
Supporting Evidence
- Transfection of p21WAF1/CIP1 inhibited [3H]thymidine incorporation in both HepG2 and PLC/PRF/5 cells.
- p21WAF1/CIP1 reduced cdk2 kinase activity by 20%.
- PLC/PRF/5 cells showed a significant inhibition of proliferation when transfected with p21WAF1/CIP1.
Takeaway
This study found that a protein called p21WAF1/CIP1 can stop liver cancer cells from growing by blocking their ability to make DNA.
Methodology
The study used two human liver cancer cell lines and examined the effects of p21WAF1/CIP1 on DNA synthesis and cell proliferation through transfection and various assays.
Participant Demographics
The study involved two human liver cancer cell lines: HepG2 and PLC/PRF/5.
Statistical Information
P-Value
p=0.0258
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website